Ubs Asset Management Americas Inc Savara Inc Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Savara Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 221,669 shares of SVRA stock, worth $778,058. This represents 0.0% of its overall portfolio holdings.
Number of Shares
221,669
Previous 159,052
39.37%
Holding current value
$778,058
Previous $440,000
14.77%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SVRA
# of Institutions
128Shares Held
167MCall Options Held
38.7KPut Options Held
0-
Nea Management Company, LLC Timonium, MD24.5MShares$85.9 Million4.63% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA17.6MShares$61.8 Million12.04% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$43.4 Million5.75% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA11.5MShares$40.2 Million1.38% of portfolio
-
Vestal Point Capital, LP New York, NY11MShares$38.7 Million1.32% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $400M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.